Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infections
Phase of Trial: Phase II
Latest Information Update: 11 Feb 2016
At a glance
- Drugs CTV 05 (Primary)
- Indications Urinary tract infections
- Focus Therapeutic Use
- 13 Jun 2012 Actual end date (Apr 2012) added as reported by ClinicalTrials.gov.
- 13 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Mar 2011 New trial record